Papers
1
Total Citations
30
H-Index
1
About
Meng Ru is a leading clinical researcher in head and neck oncology, with a focused expertise in functional outcomes following transoral robotic surgery (TORS) for oropharyngeal cancer. Her work is pivotal in the movement toward treatment deintensification, aiming to preserve quality of life without compromising oncologic control. Her most cited study, a prospective evaluation of swallowing, tongue function, and quality-of-life measures after TORS alone, provided critical evidence that surgery without adjuvant therapy can maintain swallow safety and efficiency while significantly reducing long-term toxicity. This work, accumulating over 30 citations, has helped shape clinical guidelines for patient selection and post-surgical rehabilitation. Dr. Ru’s contributions are distinguished by their rigorous, patient-centered methodology, bridging the gap between surgical innovation and real-world functional preservation. Her research continues to influence how multidisciplinary teams approach de-escalation strategies, making her a key voice in the evolving landscape of head and neck cancer care.
Research Focus
Key Achievements
Top Papers
- 1